Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Sanofi
Form 13F · Q2 2026

Sanofi

CIK 1121404Filed 2026-07-2813F-HR View the filing on EDGAR ↗
$534M
Reported book value
10
Positions
7
Quarters on record
Top 50
Positions

Sanofi — holdings

Top 10 positions of 10, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1MGTX Meiragtx Hldgs Plc12.2M+0.0%$165M30.9%
2INBX Inhibrx Biosciences Inc1.2M+0.0%$110M20.5%
3NVAX Novavax Inc6.9M+0.0%$65M12.1%
4ANAB Anaptysbio Inc821,917+0.0%$55M10.4%
5ODTX Odyssey Therapeutics Inc2.0M—$37M7.0%
6AGMB Agomab Therapeutics Nv2.8M+0.0%$36M6.8%
7MPLT Maplight Therapeutics Inc912,041+0.0%$33M6.1%
8TRAX First Tracks Biotherapeutics821,917—$17M3.1%
9IMRX Immuneering Corp2.7M+0.0%$14M2.5%
10QTTB Q32 Bio Inc244,083+0.0%$3M0.6%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.